Core Points - Celularity Inc. has been notified by Nasdaq for not timely filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025, resulting in non-compliance with Listing Rule 5250 (c)(1) [1] - The notice from Nasdaq does not have an immediate effect on the listing or trading of the Company's shares, and the Company has 60 calendar days to submit a compliance plan [2] - The Company is actively working to complete its Form 10-Q and anticipates maintaining compliance with SEC reporting obligations [3] Company Overview - Celularity Inc. is a regenerative and cellular medicine company focused on developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, utilizing the postpartum placenta [4]

Group 1 - The company Grupo Aeroportuario del Pacífico (GAP) has drawn down a credit facility of Ps. 3,375 million from Banamex with a five-year term, to be repaid by May 30, 2030 [1] - The interest on the credit facility will be paid monthly at a variable rate of TIIE-28 plus 54 basis points, with no fees [1] - The proceeds from this credit will be utilized to repay existing loans of Ps. 2,500 million from Banamex and Ps. 875 million from BBVA [1] Group 2 - GAP operates 12 airports in Mexico's Pacific region, including major cities like Guadalajara and Tijuana, and tourist destinations such as Puerto Vallarta and Los Cabos [2] - The company was listed on the New York Stock Exchange in February 2006 and on the Mexican Stock Exchange in the same year [2] - GAP acquired a majority stake in MBJ Airports Limited in April 2015, which operates Sangster International Airport in Jamaica, and entered into a concession agreement for Norman Manley International Airport in October 2018 [2]

Core Viewpoint - Perspective Therapeutics, Inc. announced updated interim results from its ongoing Phase 1/2a clinical trial of [Pb]VMT-α-NET, presented at the 2025 ASCO Annual Meeting, indicating a favorable safety profile and promising anti-tumor activity in patients with neuroendocrine tumors [1][5][11]. Clinical Trial Overview - The Phase 1/2a clinical trial is a multi-center, open-label study focusing on patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing neuroendocrine tumors who have not received prior radiopharmaceutical therapy [2][12]. - Cohort 2 was reopened for enrollment in August 2024, with a total of 33 additional patients enrolled by April 30, 2025 [4][12]. Efficacy and Safety Data - Updated interim efficacy data were presented for two patients in Cohort 1 and seven patients in Cohort 2, with a data cut-off date of April 30, 2025 [3][5]. - Among 42 patients who received at least one treatment, there were no dose-limiting toxicities (DLTs) or treatment discontinuations due to adverse events reported [4][5]. - Ten patients experienced at least one Grade 3 treatment emergent adverse event (TEAE), with the majority deemed unrelated to [Pb]VMT-α-NET [4][5]. Anti-Tumor Activity - Four of seven patients in Cohort 2 experienced investigator-assessed objective responses, with three confirmed responses [5][11]. - Seven out of nine patients in Cohorts 1 and 2 remained free from disease progression after more than one year of follow-up [5][11]. Future Plans and Regulatory Engagement - The company plans to submit longer safety follow-up data and preliminary efficacy data for a subgroup for presentation at a scientific congress in the second half of 2025 [11][12]. - The company is engaging with the FDA to continue pursuing dose finding for [Pb]VMT-α-NET [10][11]. Company Background - Perspective Therapeutics, Inc. specializes in developing advanced radiopharmaceutical treatments for cancers, utilizing proprietary technology to deliver targeted radiation to cancer cells [14][15]. - The company is also developing complementary imaging diagnostics to personalize treatment and optimize patient outcomes [14].

Core Viewpoint - Stantec Inc. has announced a private placement offering of $425 million in senior unsecured notes with a fixed interest rate of 4.374%, aimed at repaying existing debt and for general corporate purposes [1][2]. Group 1: Offering Details - The offering consists of $425 million aggregate principal amount of senior unsecured notes due June 10, 2032, with a fixed interest rate of 4.374% per annum, payable semi-annually [1][2]. - The notes will be issued at par, resulting in gross proceeds of $425 million, with interest payments commencing on December 10, 2025 [2]. - The notes will rank pari passu with all existing and future senior unsecured indebtedness of Stantec and have been assigned a provisional rating of BBB with a stable trend by DBRS Limited [3]. Group 2: Regulatory and Legal Considerations - The notes will not be qualified for public sale under Canadian securities laws and will be offered on a private placement basis [4]. - The notes have not been registered under the U.S. Securities Act and cannot be offered or sold in the United States or to U.S. persons [4]. Group 3: Company Overview - Stantec is recognized as a global leader in sustainable engineering, architecture, and environmental consulting, addressing significant challenges such as aging infrastructure and energy transition [8][9]. - The company emphasizes the importance of community engagement and diverse perspectives in its projects, aiming to innovate in areas like climate change and digital transformation [10][11].

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) is providing an update on the status of a management cease trade order granted on May 1, 2025 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203"). On May 1, 2025, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying managem ...

Company Overview - EnviroGold Global Limited is a clean technology company focused on reprocessing mine waste to produce precious and critical metals while promoting environmental and social sustainability [1][4] - The company operates on a technology licence fee model with low capital expenditure (capex) requirements and aims to establish itself as a leading global technology company focused on shareholder value [4] Management Changes - Mr. Peter Nguyen has been appointed as the Interim Chief Financial Officer, effective immediately [1] - Mr. Nguyen is a Chartered Professional Accountant with over 15 years of experience in finance, financial reporting, regulatory compliance, and public company administration [2] - This appointment follows the resignation of Mr. Kyle Appleby, effective May 20, 2025, and the company expressed gratitude for Mr. Appleby's contributions [3]

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) is pleased to announce the release of its sixth annual Environmental, Social, and Governance (“ESG”) Report, providing an overview of its ESG strategies, policies, and commitments, and outlining the progress made in 2024. Highlights from CAPREIT’s 2024 ESG Report include: Engaged employees, senior management and the Board of Trustees in an ESG double materiality assessment to further ...

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Highrock Resources Ltd. ("Highrock" or "the Company") (CSE: HRK) is pleased to announce that, further to its press release of May 21, 2025, the Company has made a cash payment in the amount of $8,000 and issued an aggregate of 200,000 common shares (each, a "Common Share") in the capital of the Company to the Optionor (as defined below) at a price of $0.05 per Common Share pursuant to option agreement (the "Option Agreement") with an arm's length optionor (the "Opti ...

VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Interfield Global Software Inc. (the “Company”) announces that consequent upon its continued restructuring for development of the previously announced joint venture with Abhi Fintech Ltd., effective May 30, 2025, Steele Hemmerich and Crae Garrett have resigned as directors of the Company. Mr. Hemmerich remains as Chief Executive Officer of the Company. The board of directors of the Company (“Board”) would like to thank Steele Hemmerich for his co ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES WINNIPEG, Manitoba, May 30, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leader in propulsion agnostic bus and coach mobility solutions, today announced that its subsidiary, New Flyer Holdings, Inc. (the “Issuer”), has entered into a binding purchase agreement with a syndicate of initial purchasers and priced its previously announced private offering of senior secu ...